ROI claims are as plentiful as the number of point solutions in digital health, so Virta’s research team recently undertook a study to understand the financial impacts of our diabetes reversal treatment using a claims-based analysis.
Validation Institute's analysis finds that Virta's diabetes reversal treatment drives estimated medication cost savings of nearly $6k per patient over 2 years.
Meet the leaders behind the heroic effort to reverse diabetes at WHA.
Canal Barge's VP of HR talks about prioritizing a progressive benefits management strategy for his employee population.
Ryan Smith, DO, shares his views on the clinical benefits of Virta’s diabetes reversal treatment and why he advocates it for his patients.
BBVA VP & Employee Benefits Consultant shares the details behind their game changing transition from diabetes management to reversal.
The Deputy Director of HR for the City of Fort Worth talks about his partnership with Virta and the resulting paradigm shift in his benefits strategy.
Nebraska Medicine's Employee Wellbeing and Safety Manager talks about caring for the caregivers and how she's used Virta to change hundreds of lives for the better.
Results show broad cardiometabolic health improvement, including blood sugar control, weight loss, and medication deprescription, with half of all diabetes drugs eliminated at 5 years.
For years, US policymakers from both parties have worked to improve affordability of prescription drugs with little success.
Each day, more health plans are looking for innovative solutions (outside of traditional diabetes management) to combat the insulin cost crisis.
Did you know that 78% of type 2 diabetes patients are unaware of “reversal”...but once they know, 87% are motivated to try it?
We use cookies on our site to give you the best experience possible. By continuing to browse the site, you agree to this use. For more information on how we use cookies, see our Privacy Policy.
